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Abstract
Oxidative stress plays a prominent role in the pathophysiology of cystic fibrosis (CF). Despite the presence of oxidative stress
markers and a decreased antioxidant capacity in CF airway lining fluid, few studies have focused on the oxidant/antioxidant
balance in CF cells. The aim of the current study was to investigate the cellular levels of reactive oxygen species (ROS),
oxidative damage and enzymatic antioxidant defenses in the lung of Cftr-knockout mice in basal conditions and as a
response to oxidative insult. The results show that endogenous ROS and lipid peroxidation levels are higher in Cftr
2/2
lung when compared to wild-type (Cftr
+/+) in basal conditions, despite a strong enzymatic antioxidant response involving
superoxide dismutases, glutathione peroxidases and peroxiredoxin 6 (Prdx6). The latter has the unique capacity to directly
reduce membrane phospholipid hydroperoxides (PL-OOH). A dramatic increase in PL-OOH levels in Cftr
2/2 lung consecutive
to in vivo oxidative challenge by paraquat (PQ) unmasks a susceptibility to phospholipid peroxidation. PQ strongly
decreases Prdx6 expression in Cftr
2/2 mice compared to Cftr
+/+. Similar results were obtained after P. aeruginosa LPS
challenge. Two-dimensional gel analysis of Prdx6 revealed one main molecular form in basal conditions and a PQ-induced
form only detected in Cftr
+/+ lung. Mass spectrometry experiments suggested that, as opposed to the main basal form, the
one induced by PQ is devoid of overoxidized catalytic Cys47 and could correspond to a fully active form that is not induced
in Cftr
2/2 lung. These results highlight a constitutive redox imbalance and a vulnerability to oxidative insult in Cftr
2/2 lung
and present Prdx6 as a key component in CF antioxidant failure. This impaired PL-OOH detoxification mechanism may
enhance oxidative damage and stress-related signaling, contributing to an exaggerated inflammatory response in CF lung.
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Introduction
Cystic fibrosis (CF), the most prevalent lethal autosomal
recessive disorder in the Caucasian population, is caused by
mutations in the cystic fibrosis transmembrane conductance
regulator gene, Cftr. The latter encodes a membrane protein,
CFTR, expressed in the apical membrane of exocrine epithelial
cells that functions as a cyclic AMP-activated anion channel.
Although CF is a multisystem disease with a typical phenotype
characterized by pancreatic insufficiency, intestinal obstruction
and male infertility, the lung disease remains as its most life-
threatening manifestation. CF lung disease is regarded as a
combination of abnormalities in electrolyte transport, epithelial
lining fluid (ELF) composition, pathogen clearance and
inflammatory response that set in motion a self-perpetuating
cycle of airway obstruction, chronic bacterial infection and
inflammation.
CF airways inflammation appears excessive and prolonged in
regard to bacterial load and associated with large numbers of
neutrophils. This chronic inflammation leads to fibrosis and the
progressive deterioration of pulmonary function in CF. Several
studies indicate that oxidant/antioxidant imbalance and oxidative
stress are important players in this scenario. Elevated levels of lipid
and protein oxidation products found in BALF, exhaled breath
condensate and sputum of CF patients [1] [2] [3] [4], provide
evidence of oxidative stress in the ELF compartment. These
oxidative damages are due to an increased oxidant burden,
resulting from the release of oxidants by neutrophils and
Pseudomonas aeruginosa that chronically infects CF airways [5].
Concentrations of glutathione in the ELF are markedly reduced in
CF patients as well as Cftr-knockout mice [6] [7], contributing to
the oxidant/antioxidant imbalance. It has been postulated that
CFTR, by participating in the apical export of reduced
glutathione (GSH) [8] [9] [10], is directly involved in the
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e6075regulation of GSH homeostasis of ELF. Thereby, CFTR could be
considered as an important actor of ELF antioxidant homeostasis
and thus an intrinsic cause of oxidative imbalance in CF airways
from human patients as well as Cftr knockout mice. The latter
appears as a suitable model to investigate the constitutive redox
imbalance in CF.
To minimize the damage on their constituents, cells rely on the
scavenging capacity of reactive oxygen species (ROS) by
enzymatic (i.e. superoxide dismutases, catalase, GSH-peroxidases)
and non-enzymatic antioxidant systems. The levels of antioxidant
enzyme expression and function are supposed to reflect the
capacity of tissues to protect from oxidant-induced injury and are
widely considered as important parameters to evaluate oxidative
stress. Among antioxidant enzymes, peroxiredoxin 6 (Prdx6) has
been recognized as a major player in the defence against lung
oxidative damage [11] [12] [13]. Prdx6 has a single redox-active
cysteine and uses glutathione as the electron donor to catalyze the
reduction of H2O2, fatty acid hydroperoxides and more
interestingly phospholipid hydroperoxides (PL-OOH) [14]. PL-
OOH can propagate an autocatalytic chain of lipid peroxidation
and generate toxic secondary products such as malonyldialdehyde
(MDA) and 4-hydroxyalkenals that are prone to form oxidative
adducts and activate stress signalling pathways. The unique ability
of Prdx6 to reduce membrane PL-OOH probably explains its
crucial role in lung antioxidant defence [15].
Although several lines of evidence indicate that pro-oxidative
conditions of ELF exacerbate deterioration of airways in CF, there
is comparatively little information about the intracellular redox
status in CF airway cells. The aim of the current study was to
evaluate (i) the enzymatic antioxidant activities, (ii) lipid peroxi-
dation levels, and (iii) the in vivo capacity of CF lung to respond to
oxidative insult in a Cftr-knockout mouse model. The results
presented here show a constitutive redox imbalance and a
vulnerability to oxidative stress involving Prdx6 in Cftr
2/2 lung.
Methods
Reagents
Media, serum and antibiotics for cell culture were purchased
from Invitrogen (GIBCOH). Chemicals for protein concentration
assessment, gel electrophoresis and transfer were purchased from
Biorad (Paris, France), primary antibodies from Abcam (Paris,
France) and Odyssey reagents from ScienceTec (Paris, France).
Animals
All animal protocols were approved by Necker Faculty of
Medicine Animal Care and Use Committee (Universite ´ Paris
Descartes); authorization no. 7514, Ministe `re de l’Agriculture et
de la Pe ˆche. Animals used in this study were Cftr-knockout (Cftr
2/2) mice homozygous for the S489X mutation (B6;129-
Cftrtm1Unc) [16] backcrossed into C57BL/6 (three generations)
and their wild-type (Cftr+/+) littermates (CDTA, Orle ´ans,
France). Pups were weaned at 21 days and fed solid mouse chow
(Teklad 2018S, Harland). Cftr 2/2 mice typically die shortly
after weaning from intestinal obstruction. A commercial osmotic
laxative containing PolyEthylenGlycol-3350 and electrolytes
(MovicolH, Norgine Pharma, Paris, France) was added to the
drinking water (1pack/250 ml) to increase the survival of Cftr
2/2 mice [17]. All mice were allowed food and water ad libitum
until the time of sacrifice by cervical dislocation.
Paraquat (PQ)-induced oxidative stress in mice
Mice (4 week-old) were injected twice (intraperitoneally) at
24 hours intervals with paraquat (methylviologen dichloride
hydrate, Sigma-Aldrich, St-Quentin, France) with doses of
30 mg/kg of body weight in normal saline (sodium chloride
0.9%, MacoPharma, Mouvaux, France). Mice were sacrificed
48 hours after the first injection.
Lipopolysaccharide (LPS) instillation
Mice (5–7 week-old) were slightly anesthetized with xylazine 2%
(8 mg/kg) (RompunH, Bayer-France) and ketamine 1000 (40 mg/
kg) (Imalge `ne 1000, Merial, Lyon, France) and received
intratracheal instillation of P. aeruginosa LPS (330 mg/kg) (serotype
10; Sigma-Aldrich, St-Quentin, France). Mice were sacrificed
24 hours later.
Harvesting and preparation of mice tissues
Tracheas were incised and cannulated to allow bronchoalveolar
lavage. Lung lobes were lavaged three times by instillation and
aspiration of 500 ml of sterile PBS pH 7.4. Right and left lungs
were rinsed with cold PBS and rapidly frozen in liquid nitrogen
and stored at 280uC for subsequent measurement of thiobarbi-
turic acid-reactive substances. For phospholipid hydroperoxide
quantification, lungs were homogenized in 500 ml of PBS before
lipid extraction. For immunohistochemistry experiments, lungs
were filled with PBS containing 50% Shandon Cryomatrix
TM
(Thermo Scientific, Cergy-Pontoise, France) and immediately
frozen in liquid nitrogen.
Isolation of tracheal cells and fluorescent measurement
of intracellular oxidant
Tracheas were dissected away from lungs and collected in ice-
cold DMEM:F-12 medium with 100 U/ml penicillin and 100 mg/
ml streptomycin before proceeding to epithelial cell isolation. This
was performed as reported by You et al [18] with slight
modifications. Tracheas were opened longitudinally and incubated
in 1 ml of DMEM:F-12 with 100 U/ml penicillin and 100 mg/ml
streptomycin containing 1.5 mg/ml of pronase (Roche applied
science, Meylan, France) for 18 h at 4uC. After adding foetal calf
serum (FCS) up to a final concentration of 10%, tracheas were
inverted 12 times to release cells and transferred to another tube.
The process was repeated twice, the three tubes were pooled and
centrifuged at 400 g for 10 min at 4uC. Cells were resuspended in
200 ml DMEM:F-12 medium with 10% FCS per trachea. At this
step, cell suspensions were pooled to have a sufficient amount of
ciliated cells for quantification. Cells were seeded in tissue culture
plates for 3–4 h in 5% CO2 at 37uC to remove fibroblasts. Non-
adherent cells were collected by centrifugation and resuspended in
Ringer solution (10 mM Hepes, 5 mM KCl, 135 mM NaCl,
1 mM MgCl2, 1 mM CaCl2 and 10 mM glucose). Cells were then
incubated for 30 min at 37uC with 1 mM of the ROS sensitive
fluorescent probe, 5-(and-6)-chloromethyl-29,79-dichlorodihydro-
fluorescein diacetate (CM-H2DCFDA, Molecular Probes, Cergy-
Pontoise, France). The incubation was performed in Lab-TekH
chamber mounted on glass slide (Nunc, Thermo Scientific, Cergy-
Pontoise, France), previously coated with BD Cell-Tak
TM (BD
Biosciences, Le-Pont-de-Claix, France) to adhere the cells. After
incubation, cells were washed twice with Ringer solution. Images
were obtained by laser confocal scanning microscopy (Zeiss LSM
510) with663 oil objectives. Only ciliated tracheal cells were used
for quantification of relative fluorescence with ImageJ software
(rsb.info.nih.gov/ij).
Thiobarbituric acid-reactive substances (TBARS) assay
Malondialdehyde, one of the several low molecular weight end
products formed via the decomposition of certain primary and
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reaction with thiobarbituric acid [19]. Lipid peroxidation was
determined by measuring the formation of TBARS using a
commercial assay kit (Cayman Chemical, Ann Arbor, MI, USA) in
accordance with the manufacturer’s protocol. TBARS concentra-
tion was calculated from a MDA standard curve and normalized
for protein content.
Determination of total superoxide dismutase (SOD)
activity
Lung tissue was homogenized (Dounce homogenizer) in 500 ml
of ice-cold buffer (20 mM Hepes pH 7.2, 1 mM EGTA, 210 mM
mannitol, 70 mM sucrose), centrifuged (1500 g for 5 min at 4uC),
and the supernatant was retained for analysis. Total SOD activity
was determined using a commercially available kit (Cayman
Chemical, Ann Arbor, MI, USA) [20] [21]. SOD specific activity
was expressed as units per gram of lung protein.
Determination of total glutathione peroxidase (GPx)
activity
Lung tissues were homogenized (Dounce homogenizer) in
750 ml of cold buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl,
1 mM EDTA, 0.5% TritonH X-100), centrifuged (10 000 g for
10 min at 4uC) and the supernatant was retained for analysis.
Total GPx activity in the homogenate was measured according to
the protocol supplied with the kit (Cayman Chemical, Ann Arbor,
MI, USA). GPx specific activity is expressed as mmole of NADPH
consumed per minute per milligram of lung protein.
Determination of Catalase (CAT) activity
Lung tissues were homogenized (Dounce homogenizer) in
500 ml of ice-cold buffer (50 mM potassium phosphate pH 7.0,
1 mM EDTA), centrifuged (10 000 g for 15 min at 4uC) and the
supernatant was retained for analysis. CAT activity was deter-
mined using a commercially available kit (Cayman Chemical, Ann
Arbor, MI, USA) [22], [23] CAT specific activity was expressed as
nmole of formaldehyde formed per minute per mg of lung protein.
Immunoblot analysis
Ten micrograms of mice lung homogenates were diluted with
Laemmli sample buffer and heated at 95uC for 3 min. Proteins
were resolved by 12% SDS-polyacrylamide gel electrophoresis and
electrotransferred onto a PVDF membrane. After transfer, analysis
was performed following manufacturer’s recommendations for the
OdysseyH infrared imaging system (LI-COR Biosciences, NE,
USA). Dilution of rabbit polyclonal antibodies to Prdx6 (Abcam,
Paris, France) was 1:2,000 and 1:10,000 for the fluorescent
IRDyeH TM700 secondary antibody (ScienceTec, Paris, France).
Images were acquired with the Odyssey infrared imaging system.
Quantification of protein bands was performed with the Odyssey
software. Membranes were also probed with mouse monoclonal
antibody to a-tubulin from AbCam (1:10,000) and IRDyeH
TM800 secondary antibody from ScienceTec (1:10,000) to correct
for protein loading.
Immunohistochemical staining
Six-micrometer cryosections of mouse tissues were fixed with
cold acetone for 10 min at 4uC. All steps were carried out in a
humid chamber. Sections were rehydrated in PBS and permea-
bilized with 0.25% TritonH X-100 in PBS. Nonspecific binding
sites were blocked with 3% bovine serum albumin in 0.1%
TritonH X-100 in PBS (PBS-T) before incubation with a dilution
of Prdx6 primary antibody (1:1,200) in 1% bovine serum albumin
in PBS-T. After washing and blocking with 5% goat serum in
PBS-T, sections were incubated with Alexa FluorH 594 goat
anti-rabbit secondary antibody (Molecular Probes, Cergy-
Pontoise, France) diluted 1:1,000 in PBS-T and subsequently
mounted in Vectashield mounting medium (Abcys, Paris,
France). Tissue sections were examined under a confocal laser
scanning microscope (Zeiss LSM 510). Images were collected
with 640 or 663 oil objectives.
Quantitative Real-Time PCR
Total RNAs were isolated using TRIzol reagent following
manufacturer’s recommendations (Invitrogen, Cergy-Pontoise,
France), dissolved in RNAse-free water and measured at
260 nm. Gene expression was studied by quantitative Real-Time
PCR using the cycle threshold (CT)-based method [24]. Five mgo f
total RNA was used to synthesize cDNA (First-strand cDNA
Synthesis Kit, GE Healthcare, Orsay, France) with random
hexadeoxynucleotides and reverse transcriptase for 1 h at 37uC.
The LightCycler FastStart DNA Master PLUS SYBR Green I kit
was used with a LightCycler (Roche applied science, Meylan,
France) for quantitative PCR. The relative expression of each
target gene was normalized to a reference gene, b-actin. Gene
specific primers were chosen using Primerbank (pga.mgh.Harvar-
d.edu/primerbank). The primers for Prdx6 were forward:
CGCCAGAGTTTGCCAAGAG and reverse:
TCCGTGGGTGTTTCACCATTG. The primers for b-actin
were forward: AGTGTGACGTTGACATCCGTA and reverse:
GCCAGAGCAGTAATCTCCTTCT.
Phosphatidylcholine hydroperoxide (PC-OOH)
quantification
Lung wet weight was 0.14 g60.01 g for Cftr
2/2 and
0.23 g60.01 g for Cftr
+/+ mice. Lung tissue lipids were extracted
by adding 3 ml of chloroform:methanol 12:1 (vol/vol) to the whole
lung homogenate, vortexing for 10 sec and centrifuging at 800 g
for 5 min at 4uC. The lower organic phase was collected and
evaporated to dryness under a nitrogen stream. Separation and
detection of phosphatidylcholines (PC) and their corresponding
hydroperoxides (PC-OOH) were performed as previously de-
scribed [25]. Briefly, the entire extract of dried lipids was dissolved
in methanol and then injected for HPLC separation, using an RP-
18 (Kromasil 25064.6 mm, 5 mm particles) analytical column
maintained at 40uC. The mobile phase was composed of 6%
10 mM ammonium acetate pH 5.0 and 94% methanol. The
molecular species of PC were detected at 205 nm and PC-OOH
were detected by a Jasco CL-925 chemiluminescence detector
(Japan Spectroscopic Co, Tokyo, Japan) in a post-column reaction:
eluting hydroperoxides reacted with the chemiluminescent reagent
prepared by dissolving microperoxidase (10 mg/l) and isoluminol
(55 mg/l) in a mixture of borate buffer (0.1 M, pH 9.2, 300:700
vol/vol). Peaks corresponding to molecular species of PC and PC-
OOH were identified from the same HPLC injection by their
retention time relative to standards: PC standards were purchased
from Avanti Polar Lipids (Alabaster, AL, USA) and their
corresponding PC-OOH were prepared by lipoxygenase treat-
ment [26]. Molecular species of PC-OOH (1-palmitoyl-2-lino-
leoyl-phosphatidylcholine (PLPC) [16:0-18:2-OOH], 1-palmitoyl-
2-arachidonoyl-phosphatidylcholine (PAPC) [16:0-20:4-OOH]
and 1-palmitoyl-2-docosahexaenoyl-phosphatidylcholine (PDPC)
[16:0-22:6-OOH] were quantified by their peak height normalized
to the peak height of the corresponding non-peroxidized PC. As
PAPC-OOH and PDPC-OOH had the same retention time they
were quantified together.
Prdx6, Oxidative Stress in CF
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The content of carbonyl group in lung protein was assessed by
the ELISA method using a commercially available kit (Immun-
diagnostik AG, Bensheim, Germany) in accordance with the
manufacturer’s protocol. Lung tissue was homogenized (Dounce
homogenizer) in 500 ml of ice-cold PBS, centrifuged (10 000 g for
10 min at 4uC), and the supernatant was retained for analysis. The
carbonyl protein content was calculated from a standard curve
prepared with oxidized bovine serum albumin and normalized for
protein content.
Two-dimensional (2D) gel electrophoresis
The 2D gel techniques were adapted from Bensalem et al
[27]. Aliquots of mouse lung homogenates were resolubilized in
buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, 0.5%
dithiothreitol and 1% ampholyte pH 4–7. Samples were applied
by in-gel rehydration (50 V, 10 h) and isoelectrofocusing (IEF)
was performed on immobilized pH gradient strips (pH 4–7, GE
Healthcare, Orsay, France). Seven cm strips (25 mg protein load,
125 ml rehydration volume) were used with gels for immuno-
blotting and 18 cm strips (350 mg, 450 ml) were used with gels
for mass spectrometry. IEF was performed for a total of
,16 kVh (immunoblotting) or ,60 kVh (mass spectrometry).
Prior to SDS-PAGE on a 12% polyacrylamide gel, strips were
incubated at room temperature in equilibration buffer (50 mM
Tris-HCl pH 8.8, 6 M urea, 2% SDS) with 2% DTT for
10 min and for another 10 min with 2.5% iodoacetamide.
Immunoblotting with Prdx6 antibodies was performed as
described above. Gels for mass spectrometry were fixed, washed
and proteins were visualized by the silver staining method as
previously described [28].
Mass spectrometry and Database Searching
The peptide mixture obtained by the standard in-gel tryptic
digestion procedure (including reduction and alkylation) was
applied to an RP-18 precolumn (Waters NanoAcquity
Figure 1. Intracellular ROS and lipid peroxidation levels. A) Endogenous ROS levels in ciliated tracheal cells. Epithelial cells freshly isolated from
trachea were incubated with CM-H2DCF-DA and visualized by fluorescent confocal microscopy. Under identical imaging conditions, DCF fluorescence
was markedly increased in ciliated epithelial cells from Cftr
2/2 mice (left) as confirmed by quantification of relative fluorescence (right). Values
represent fluorescent intensity (arbitrary units, a.u.) and data correspond to the mean6S.E. of n=90 for Cftr
+/+ and n=71 for Cftr
2/2 cells, obtained
from five animals of each genotype. B) Lipid peroxidation in lung tissue. Levels of TBARS were significantly elevated in lung tissue from Cftr
2/2 mice.
Values are presented as malondialdehyde equivalences (micromole per gram of lung protein), mean6S.E., n=9 from 2 different experiments, in
duplicate). * P#0.05, *** P#0.001
doi:10.1371/journal.pone.0006075.g001
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acid as a mobile phase and then transferred to a UPLC RP-18
column (Waters NanoAcquity 250 mm675 mm) using an
acetonitrile gradient (0–50% in 30 min) in the presence of
0.1% formic acid at a flow rate of 250 nL/min. The column
outlet was directly coupled to the ion source of the Ion
Cyclotron Resonance spectrometer (LTQ-FTICR, Thermo
Electron), working in the regime of data-dependent MS to
MS/MS switch. The resulting mass spectra were used to search
the nonredundant protein database of the National Center of
Biotechnology Information (NCBInr version 20080624) using
the MASCOT (matrixscience.com) search engine (8-processor
on-site license). Standard search parameters were set as follows:
taxonomy restriction – Mus musculus, enzyme – semi-trypsin,
variable modifications – carbamidomethylation (C), oxidation
(M), protein mass – unrestricted, peptide mass tolerance
2640 ppm, fragment mass tolerance 260.8 Da, max missed
cleavages 21. A second search was performed using the error
tolerant function of Mascot. This mode allows iterating selected
proteins through a list of chemical and post-translational
modifications present in the UniMod database (www.unimod.
org). Potential modifications were validated by manual inspec-
tion of the MS/MS data. Hits were accepted if all strong peaks
in the MS/MS spectrum were assigned either to y- or b-series
ions and the spectrum contained y- or b-series signals
corresponding to at least a stretch of three or more consecutive
amino acids.
Statistical analysis
Unpaired Student’s t test was used for comparison of means and
P values #0.05 were considered statistically significant. Data were
expressed as mean6S.E.
Results
Abnormal oxidant/antioxidant status in airway cells from
Cftr
2/2 mice
The intracellular oxidant status of freshly isolated tracheal cells
from Cftr
2/2 mice and their Cftr
+/+ littermates was analyzed using
the fluorescent indicator CM-H2DCFDA. As shown in Fig. 1A,
the level of DCF fluorescence was 1.5 times greater (P=0.0005) in
Cftr
2/2 ciliated cells when compared to Cftr
+/+, revealing a higher
steady state level of intracellular ROS in Cftr
2/2 airway epithelial
cells.
To investigate whether this elevated level of intracellular ROS
in Cftr
2/2 cells was associated with an increased level of oxidation-
damaged macromolecules, we evaluated lipid peroxidation in lung
homogenates using the TBARS assay (Fig. 1B). TBARS levels
were slightly but significantly higher (P=0.014) in Cftr
2/2 mice
when compared to Cftr
+/+.
To determine whether decreased antioxidant defences could
account for the increased levels of ROS and peroxidized lipids in
Cftr
2/2 lung, the activities of the main antioxidant enzymes in
lung, e.g., SOD, GPx and CAT, were evaluated. No difference in
CAT activity was measured between Cftr
2/2 and Cftr
+/+ (Fig. 2A).
In contrast, total SOD and GPx activities exhibited a significant
increase (P=0.05 and P=0.044) in Cftr
2/2 lung (Fig. 2B and C).
While GPx activity presented a small increase, SOD activity was
almost double in Cftr
2/2 lung extracts.
The presence of elevated ROS and lipid peroxidation levels
despite higher total GPx and SOD activities in Cftr
2/2 raised the
possibility that some important antioxidant defences could be
defective in Cftr
2/2 airway cells. As Prdx6 is a major lung
antioxidant and a unique phospholipid hydroperoxide detoxifica-
tion system in this tissue, we further investigated its expression
level in Cftr
2/2 lung. As shown in Fig. 3A, a 1.8-fold increase
(P=0.0021) in Prdx6 protein expression was measured in Cftr
2/2
lung by quantitative immunoblot. In contrast, no difference in
Prdx6 expression was observed in skeletal muscle, a tissue where
CFTR is not expressed (data not shown).
Quantitative RT-PCR analysis showed a 1.6-fold increase
(P=0.024) in Prdx6 mRNA in Cftr
2/2 as compared to Cftr
+/+ lung
(Fig. 3B).
Immunofluorescence analysis revealed an abundant Prdx6
staining in bronchiolar epithelial cells (Fig. 3C). A subset of
alveolar cells, probably corresponding to type II pneumocytes or
macrophages were also stained but to a lesser extent. The Prdx6
distribution pattern was similar in both types of mice, but staining
Figure 2. Antioxidant enzymatic activities. Comparison between Cftr
+/+ and Cftr
2/2 mice of SOD (A), GPx (B) and CAT (C) activities in lung
homogenates. Enzymatic activities were measured by standard spectrophotometric methods. Lung homogenates from Cftr
2/2 mice displayed
significantly higher SOD and GPx activities than those from Cftr
+/+ mice. Both Cftr
+/+ and Cftr
2/2 mice displayed a similar level of CAT activity. Values
are presented as specific activity (mean6S.E., n=5, in duplicate). * P#0.05
doi:10.1371/journal.pone.0006075.g002
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+/+ and Cftr
2/2 mice were subjected
to immunoblot analysis using antibodies against Prdx6 (top) and a-tubulin (bottom). On the left, a representative blot obtained with three pairs of
mice is presented. It shows that Prdx6 expression levels are higher in Cftr
2/2 lung compared to Cftr
+/+, as confirmed on the right by quantitative
analysis. Individual data were quantified as ratio of fluorescence intensity for Prdx6 bands to the intensity obtained for a-tubulin. Data are shown as
percent of Cftr
+/+ (mean6S.E., n=9 from 2 different experiments). B) Prdx6 mRNA levels. Total lung RNA from Cftr
+/+ and Cftr
2/2 mice was reversely
transcribed and the amounts of cDNAs coding for Prdx6 and the reference protein b-actin were measured by quantitative Real-Time PCR. Prdx6
mRNAs are increased in Cftr
2/2 lung compared to Cftr
+/+. Indicated values represent the ratio of Prdx6 mRNAs to b-actin mRNAs (mean6S.E., n=8, in
triplicate). C) Immunohistochemical analysis of Prdx6. Acetone-fixed lung cryosections from Cftr
+/+ and Cftr
2/2 mice were incubated with an anti-Prdx6
antibody and visualized by confocal microscopy. Sections of bronchioles from Cftr
+/+ (a) and Cftr
2/2 (c) mice and the alveolar region from Cftr
+/+ (b)
and Cftr
2/2 (d) mice are shown. Cftr
2/2 lung sections present higher Prdx6 staining intensity compared to Cftr
+/+ mice. * P#0.05, ** P#0.01
doi:10.1371/journal.pone.0006075.g003
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2/2 lung sections, which is
consistent with immunoblotting results.
All together, these results showed that airway cells from Cftr
2/2
mice exhibit modifications of their oxidant and antioxidant status
together with a slightly increased lipid peroxidation, providing
evidence of moderate oxidative stress in the lung of mice lacking
CFTR, before any sign of chronic inflammation.
PC-OOH accumulation and increased protein carbonyl in
PQ-challenged Cftr
2/2 lung
The observed increase in Prdx6 expression in Cftr
2/2 lung
prompted us to examine their ability to control phospholipid
peroxidation when exposed to an oxidative challenge in vivo. For
this purpose, mice were treated with paraquat (PQ), known to be
selectively accumulated in the lung [29], where it leads to ROS
generation and initiates membrane damaging processes via lipid
peroxidation. Mice were injected I.P. twice at a 24 h interval with
either PQ or saline. Lungs were analysed 48 h after the first
injection for their content in phosphatidylcholine hydroperoxides
(PC-OOH) by HPLC and chemiluminescence detection. The
treatment did not compromise the survival of Cftr
2/2 mice (not
shown). Basal levels of PC-OOH were low and not significantly
different in untreated Cftr
2/2 vs Cftr
+/+ mice (Fig. 4). As expected,
PQ administration induced a significant increase in PC-OOH
content in both types of mice. Interestingly, for the same PQ load,
the PC-OOH content was significantly higher in Cftr
2/2 lung as
compared to Cftr
+/+ (P=0.043 for PAPC-OOH (Fig. 4, left) and
P=0.021 for PAPC/PDPC-OOH (Fig. 4, right)). PQ treatment
resulted in a 9- (P=0.001) and 4-fold (P=0.0002) increase of
PLPC-OOH levels in Cftr
2/2 and Cftr
+/+ lungs, respectively.
For PAPC/PDPC-OOH -fold increases were 5 (P=0.0001) for
Cftr
2/2 and 4 (P=0.0001) for Cftr
+/+.
Protein carbonyls are formed by a variety of oxidative
mechanism and are hallmarks of oxidation status of proteins.
We evaluated if the paraquat challenge resulted in changes in the
level of protein carbonyls. The results from the ELISA assay
showed that carbonyl content was higher in Cftr
2/2 lung
(234.266.8 pmol/mg protein) as compared to Cftr
+/+
(194.8610.6 pmol/mg protein, n=5, P=0.014) after the treat-
ment with PQ.
Decreased Prdx6 expression in PQ-challenged Cftr
2/2
lung
Next, we evaluated Prdx6 expression after PQ treatment
(Fig. 5). Immunoblot analysis revealed that Prdx6 protein
expression was decreased after PQ in both Cftr
2/2 and Cftr
+/+,
with a much more pronounced -fold decrease in Cftr
2/2 mice, 3-
fold (P=0.001) vs 1.8-fold (P=0.094) for Cftr
+/+, revealing that
both mice presented comparable Prdx6 protein levels after PQ
treatment (Fig. 5A).
As shown in Fig. 5B, Prdx6 protein expression parallels its
mRNA levels, as revealed by quantitative RT-PCR analysis. PQ
treatment resulted in a 1.8- (P=0.047) and 1.6-fold decrease
(P=0.05) of Prdx6 mRNA levels in Cftr
2/2 and Cftr
+/+ lung,
respectively. Immunohistochemistry analysis showed a decreased
intensity in Prdx6 staining after PQ challenge in both Cftr
+/+ and
Cftr
2/2, confirming immunoblot results (Fig. 5C). Moreover, it
showed that PQ does not induce any noticeable change in the
cellular and subcellular localization of Prdx6.
Decreased Prdx6 expression in lung from Cftr
2/2 mice
exposed to P. aeruginosa LPS
Colonization by P. aeruginosa is characteristic of CF lung disease.
P. aeruginosa LPS is a well known physiological inducer of ROS
production by neutrophils in lung. To evaluate the levels of Prdx6
expression during oxidative challenge induced by P. aeruginosa,
mice received intratracheal instillation of either P. aeruginosa LPS or
saline and lungs were analysed 24 h later. Results were
comparable to those obtained after PQ challenge (Fig. 6), i.e.
Prdx6 expression was more strongly decreased after LPS (4-fold,
P=0.05) in Cftr
2/2 lung than in Cftr
+/+ (1.4-fold decrease,
P=0.54). Because neutrophil activation in response to LPS is
Figure 4. Phosphatidylcholine hydroperoxides quantification. Cftr
+/+ and Cftr
2/2 mice were injected I.P. twice with paraquat (PQ) (+)o r
saline (2) at 24 h intervals and sacrificed 48 h after the first injection. After lipid extraction, phosphatidylcholines (PC) and their corresponding
hydroperoxides (PC-OOH) were separated by HPLC and detected by UV and chemiluminescence. After PQ challenge PLPC-OOH (16:0–18:2), PAPC–
OOH (16:0–20:4) and PDPC–OOH (16:0–22:6) were significantly higher in Cftr
2/2 lung compared to Cftr
+/+. Data are expressed as the ratio of PC–OOH
to PC peak heights (mean6S.E.) and are representative of 3 different experiments with at least n=3 animals in each experiment. * P#0.05,
*** P#0.001
doi:10.1371/journal.pone.0006075.g004
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protein extracts from Cftr
+/+ and Cftr
2/2 mice treated with either PQ (+) or saline (2) were subjected to immunoblot analysis using antibodies against
Prdx6. The decrease in Prdx6 protein after PQ exposure is greater in Cftr
2/2 mice than in Cftr
+/+. On the left, a representative blot is presented.
Individual data were quantified as ratio of fluorescence intensity for Prdx6 bands to the intensity obtained for a-tubulin. Data are shown as percent of
Cftr
+/+ treated with saline (mean6S.E., n=5 for saline and n=10 for PQ). B) Prdx6 mRNA levels after PQ treatment. Total lung RNA from Cftr
+/+ and
Cftr
2/2 mice treated with either PQ (+) or saline (2) was reversely transcribed and the amount of cDNAs coding for Prdx6 and the reference protein b-
actin were measured by quantitative Real-Time PCR. The decrease in Prdx6 mRNA after PQ challenge is greater in Cftr
2/2 mice than in Cftr
+/+.
Indicated values correspond to the ratio of Prdx6 to b-actin mRNA (mean6S.E., n=8 for saline and n=5 for PQ, in triplicate). C) Immunohistochemical
analysis of Prdx6 after PQ treatment. Acetone-fixed cryosections from Cftr
+/+ and Cftr
2/2 mice treated with PQ or saline were incubated with anti-
Prdx6 antibodies and visualized by confocal microscopy. Panels correspond to sections of bronchioles from Cftr
+/+ mice treated with either saline (a)
or PQ (b) and from Cftr
2/2 mice treated with saline (c) or PQ (d). Prdx6 staining intensity was lower after PQ exposure. * P#0.05, *** P#0.001
doi:10.1371/journal.pone.0006075.g005
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2/2 lung [30] and results in higher ROS
production, LPS challenge was not used in this study to compare
the antioxidant ability of Cftr
2/2 and Cftr
+/+ lung.
Different forms and post-translational modifications of
Prdx6 after PQ challenge
Equivalent levels of Prdx6 in Cftr
+/+ and Cftr
2/2 lung after
exposure to PQ, together with a diminished capacity to eliminate
PC-OOH in Cftr
2/2 mice suggest a compromised antioxidant
function of Prdx6 that could be associated with post-translational
modifications. In order to look for the presence of different forms
of Prdx6 that could reflect such modifications, lung protein
extracts from mice treated with either PQ or saline were subjected
to 2D electrophoresis followed by immunoblotting with an anti-
Prdx6 antibody (Fig. 7). 2D electrophoresis allowed to resolve
three Prdx6 forms (pI ,5.9, ,6.3 and ,6.7). pI 5.9 and 6.3 forms
are detected in both mouse types and in both conditions.
Interestingly, the pI 6.7 spot is present only in Cftr
+/+ lung after
PQ treatment.
To characterize the different Prdx6 forms, spots corresponding
to pI 6.3 and 6.7 were subjected to trypsin digestion and analyzed
by mass spectrometry. The pI 5.9 spot was not analysed, as it was
not detected by silver staining. Both spots were unambiguously
identified as Prdx6 with high Mascot protein score and sequence
coverage (Table 1). In the next step, error tolerant searches were
performed for detection of post-translational modifications. An
oxidative modification of Cys-47 (the cysteine of the active site for
peroxidase function) to cysteine sulfonic acid (Cys47-SO3H) was
identified only in the MS/MS spectrum from the pI 6.3 spot. The
fragmentation spectrum (Fig. 8) of the observed peak (m/z
=639.81, doubly charged) matches the tryptic peptide
DFTPVCTTELGR, corresponding to Prdx6 amino acid residues
42 to 53, plus three oxygen atoms. This spectrum provided enough
sequence information for unequivocal assignment of Cys-47
oxidation to cysteine sulfonic acid. Despite a better Prdx6
sequence coverage for the pI 6.7 compared to the pI 6.3 spot,
neither parent nor daughter ions corresponding to the peptide
bearing the Cys47-SO3H modification were detected in the pI 6.7
spot. These data indicate that the PQ-induced population of Prdx6
observed only in Cftr
+/+ mice does not contain the overoxidized
cysteine, but only its reduced form.
Discussion
The diversity of cellular abnormalities associated with CFTR
deficiency suggest that CFTR is more than a chloride channel and
is somehow connected to a plethora of functions, as indicated by
recent proteomic investigations of CF models [31]. Recent
evidence showing that CFTR expression and function are
modulated by oxidative stress [32] [33] [34] and that CFTR
controls extracellular glutathione levels [8] [9] [10] suggest that
loss of CFTR function may result in a poor adaptive response to
oxidants. Until now, most studies dealing with oxidative stress in
CF lung have focused on the oxidant and antioxidant status of the
extracellular compartment. The current study presents evidence of
higher levels of intracellular ROS and lipid peroxidation in basal
conditions, despite a strong enzymatic antioxidant response
mobilizing SOD, GPx, and, more particularly, Prdx6. In vivo,
oxidative stress challenge induced by paraquat unmasks an
increased susceptibility to phospholipid peroxidation and protein
carbonylation in the lung from mice lacking CFTR. In addition,
abnormal post-translational modifications of Prdx6 in response to
PQ-induced oxidative stress in Cftr
2/2 cells might explain their
compromised ability to reduce PL-OOH.
Our results clearly indicate that important alterations in both
oxidant and antioxidant status of airways, and subsequent
oxidative damage, are early events in the life of Cftr
2/2 mice
Figure 6. Prdx6 protein expression levels after LPS treatment. Lung protein extracts from Cftr
+/+ and Cftr
2/2 mice treated with either LPS (+)
or saline (2) were subjected to immunoblot analysis using antibodies against Prdx6. The decrease in Prdx6 protein after LPS exposure is greater in
Cftr
2/2 than in Cftr
+/+ lung. On the left, a representative blot is presented. Individual data were quantified as ratio of fluorescence intensity for Prdx6
bands to the intensity obtained for a-tubulin. Data are shown as percent of Cftr
+/+ treated with saline (mean6S.E., n=5 for saline and n=4 for LPS ).
*P #0.05
doi:10.1371/journal.pone.0006075.g006
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mice lacking CFTR. In airway cells freshly isolated from Cftr
+/+
and Cftr
2/2 mice, steady state levels of intracellular ROS, i.e.
H2O2, are higher in the latter (Fig. 1A). Comparable results have
been reported by Day et al [35] who used the H2DCF-DA probe to
evaluate H2O2 levels in the human cell line IB3 and its CFTR-
corrected counterpart, S9. Under this pro-oxidative environment,
enhanced oxidative damage can be expected, since H2O2 is
supposed to give rise to the highly reactive and deleterious
hydroxyl radical (OH
N) through the Fenton reaction [36].
Accordingly, we found lipid peroxidation, as measured by the
TBARS assay, slightly but significantly higher in lung tissue from
Cftr
2/2 mice as compared to their Cftr
+/+ littermates (Fig. 1B).
In contrast to the TBARS assay, direct HPLC analysis of
phospholipid hydroperoxides did not give any indication of
increased lipid peroxidation in Cftr
2/2 lung. The lack of
correlation between the two methods is not surprising and may
result from the fact that PL-OOH are labile and rapidly
decomposed, unlike the more stable MDA, formed via the
decomposition of lipid peroxide products, which is used as a
reliable index of lipid peroxidation.
Lipid peroxidation in Cftr
2/2 lung is likely to be a consequence
of increased intracellular ROS, even in the absence of any
detectable extracellular sources, like neutrophil infiltration or
bacterial colonization. It has been recently shown that dysfunc-
tional CFTR leads to a mitochondrial oxidative imbalance that
appears to be a consequence of lower mitochondrial GSH levels
[35]. The unopposed mitochondrial-derived ROS could then
contribute to oxidative damage to lipids and other cell macro-
molecules.
High levels of intracellular pro-oxidant compounds generally
lead to an adaptive response that results in stimulation of
antioxidant enzymes, like SOD, GPx or CAT, which provide cell
protection against oxidative damage [37]. We have shown
elevated levels of both SOD and GPx activities, with a much
more pronounced -fold increase in SOD compared to GPx in lung
from Cftr
2/2 mice (Fig. 2). The ratio between the activity of the
first (SOD) and second (GPx) step of antioxidant defence, rather
than the absolute levels of these enzymes per se, may represent an
important determinant of antioxidant function [38]. Taking into
account this physiologically critical role of the balance between
both enzymes, the significant increase in SOD/GPx ratio observed
in Cftr
2/2 lung, mainly due to a drastic increase in SOD activity,
may favor O2
N2 to H2O2 conversion leading to H2O2 accumu-
lation. These enzymatic data are consistent with the observed
increase in intracellular ROS in Cftr
2/2 cells (Fig. 1).
We have evaluated the in vivo capacity of lung to respond to
oxidative insult induced by paraquat, which essentially targets this
organ [29]. PQ administration resulted in a higher level of
phospholipid peroxidation (Fig. 4) as well as protein carbonylation
in Cftr
2/2 lung compared to Cftr
+/+. Since intracellular ROS levels
were comparable in Cftr
2/2 vs Cftr
+/+ airway cells after PQ (data
not shown), we assume that increased phospholipid peroxidation
was due to a marked decreased ability of Cftr
2/2 cells to limit
phospholipid peroxidation. This phenomenon probably results
from an inefficient adaptive response to an oxidative burden. The
failure to fully protect from oxidative injury is likely to occur
during CF infection/inflammation, when activated neutrophils
produce high levels of ROS. Lipid peroxidation products, such as
MDA, can strongly activate redox-dependant pathways that
increase inflammatory cytokine production and contribute to the
exaggerated inflammatory responses in CF.
Among lung peroxidases, Prdx6 has the unique ability to reduce
PL-OOH, as other PL-OOH reductase enzymes have limited or
no activity in this tissue [39] [40] [41]. It was therefore expected
that this antioxidant would be basally activated in Cftr
2/2 cells.
Accordingly, quantitative RT-PCR and immunoblot analyses
showed a significant and similar increase of Prdx6 expression at
the mRNA and protein levels in Cftr
2/2 lung (Fig. 3), suggesting
that upregulation of Prdx6 is mainly controlled at the mRNA level.
In alveolar type II cells isolated from adult rats subjected to
hyperoxia, mRNA and protein levels of Prdx6 increased by 1.5- to
2-fold [42]. An opposite down-regulation of Prdx6 expression has
recently been observed in the liver of a mouse model of chronic
ethanol consumption [43]. Interestingly, Pak et al [44] have shown
that mRNA and protein levels of Prdx6 are increased in human
lens epithelial cells in response to moderate concentrations of
H2O2, but decreased below control levels when a higher dose of
H2O2 is used.
In the present study, a similar dose-dependent reverse effect
exerted by ROS might explain the higher Prdx6 expression level
observed in Cftr
2/2 cells in basal conditions, as well as the down-
regulation of the enzyme in both Cftr
2/2 and Cftr
+/+ after
oxidative challenge (Fig. 5 and 6). By triggering a PMN response,
LPS instillation is a strong inducer of ROS production in the lung.
Our finding that both LPS and PQ challenges have a similar effect
on Prdx6 expression suggests that the dramatic down-regulation of
Prdx6 expression induced by PQ in Cftr
2/2 lung is not specifically
related to PQ and may occur during lung infection by P. aeruginosa.
In addition, the PQ challenge experiment suggests that Prdx6
Figure 7. 2D immunoblot analysis of Prdx6 forms after
paraquat treatment. Lung protein extracts from Cftr
+/+ and Cftr
2/2
mice treated with either paraquat (PQ) or saline (control) were
subjected to immunoblot analysis after IEF/SDS-PAGE. Two forms (pI
,5.9 and ,6.3) are present in Cftr
+/+ and Cftr
2/2 lung treated or not
with PQ. An additional form of Prdx6 (pI ,6.7) is only detected in lung
extracts form Cftr
+/+ mice treated with PQ. For both conditions,
immunoblots are representative of n=4 animals of each genotype.
doi:10.1371/journal.pone.0006075.g007
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level (Fig. 5).
The regulation of the Prdx6 gene has recently been investigated
in mouse liver [45] and in the human lung epithelial cell line A-
549 [46]. In the latter, Prdx6 expression is up-regulated by the
redox-sensitive transcription factor Nrf-2, which binds a func-
tional antioxidant response element (ARE) on the Prdx6
promoter. Since CF epithelial cells exhibit significantly lower
expression and transcriptional activity of Nrf-2, as demonstrated
by a recent study [47], it is unlikely that Nrf-2/ARE is
responsible for the increased basal expression of Prdx6 mRNA
in Cftr
2/2 cells. Conversely, it has been shown that NF-kB
inhibition leads to a marked increase in Prdx6 mRNA [45]. Such
an inverse relationship between NF-kB activation and Prdx6
expression has also been reported by Roede et al [43] in a murine
model of chronic ethanol consumption. Due to the fact that both
in vivo PQ administration [48] and LPS challenge induce a strong
and sustained increase in NF-kB activation in the lung, it is
reasonable to suggest that NF-kB may represent a major player
in the down-regulation of Prdx6 expression consecutive to PQ
and LPS treatments. A number of publications have reported an
abnormal NF-kB regulation in CF airway cells [49] [50] [51].
For instance, Cftr-knockout mice challenged by intratracheal
instillation of P. aeruginosa fail to regenerate I-kB alpha, once it is
degraded. As a consequence, they show an excessive and
prolonged lung activation of NF-kB [50].
Figure 8. Cysteine 47 overoxidation to sulfonic acid in Prdx6 extracted from pI 6.3 spot. Fragmentation spectra of DFTPVC(SO3H)TTELGR
peptide, corresponding to Prdx6 amino acid residues 42–53, unequivocally indicates oxydation of Cys47 to sulfonic acid. The most abundant peaks
(singly charged) of the peptide are annotated as b- and y- series daughter ions, in red and blue respectively. Fragmentation spectra of the non-
oxidized peptide show a similar fragmentation pattern, with a mass shift of 48 Da on peaks with oxidized cysteine (data not shown).
doi:10.1371/journal.pone.0006075.g008
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Cftr
2/2 lung leads to a Prdx6 expression level equivalent to that in
Cftr
+/+, without any change in subcellular localization. However
Cftr
2/2 lung presents a lower ability to limit phospholipid
peroxidation. It can be therefore hypothesized that Cftr
2/2 lung
presents a compromised Prdx6 peroxidase function resulting from
protein modification. To test this hypothesis, we performed 2D
electrophoresis and mass spectrometry analysis. 2D analysis did
not allow to resolve differentially expressed Prdx6 populations in
resting conditions, as two main Prdx6 spots ( pI 5.9 and pI 6.3)
were detected in both Cftr
+/+ and Cftr
2/2 lung extracts (Fig. 7). By
contrast, from the same analysis after lung exposure to PQ
resolved a Prdx6 population, at pI 6.7, appearing solely in Cftr
+/+.
Mass spectrometry analysis indicated that the PQ-induced Prdx6
population contains the reduced cysteine 47 but not its
sulfonylated form that is present in the pI 6.3 spot (Fig. 8).
Overoxidation of this redox-active cysteine to a sulfinic or sulfonic
derivative is supposed to be irreversible in vivo [52], resulting in a
non-functional enzyme [53] [54] [55]. If the PQ-induced Prdx6
population in Cftr
+/+ cells corresponds to an active form, this
population would decrease the proportion of overoxidised inactive
forms of Prdx6 in Cftr
+/+ lung. Biochemical characterisation of the
stress-induced Prdx6 population at pI 6.7 is currently under
investigation. We can speculate that this stress-induced Prdx6
population may represent an adaptive modification of the Prdx6
protein to limit its overoxidation and to maintain its antioxidant
activity in response to a strong oxidative burden. An example of
modification has been recently reported by Parmigiani et al [56]
for other two members of the peroxiredoxin family. The authors
show that acetylation of Prdx1 and Prdx2 increases their activity
and their relative resistance to overoxidation. Further studies are
needed to determine how a CFTR defect contributes to abnormal
Prdx6 modification in response to oxidative stress.
In conclusion, our results indicate that despite a significant
activation of the main cellular antioxidant defences, the lung of
Cftr
2/2 mice presents higher levels of ROS and lipid peroxidation
products. Importantly, attenuation of lung antioxidant defences by
a significant decrease in Prdx6 expression and abnormal post-
translational modification during an additional oxidative stimulus,
strongly enhances phospholipid peroxidation. Prdx6 failure may
represent an important underlying mechanism in the progression
of epithelial dysfunction in CF in response to oxidative insult.
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